Section 9006 of the Patient Protection and Affordable Care Act, which institutes new requirements for information from employers, might soon be repealed. Sec. 9006 is expected to raise $17.6 billion over ten years, but it has been criticized for being overly costly to business owners. Senator Max Baucus (D-MT) offered an amendment Friday to the FDA Modernization Act that would repeal Sec 9006.
Baucus’s amendment does not provide guidance for offsetting the cost of the repeal. A similar amendment offered by Senator Mike Johanns (R-NE) also repeals Sec. 9006 but provides for the lost revenue with a decrease in non-defense spending.
Senate Majority Leader Harry Reid has indicated the Senate will complete consideration of the FDA Modernization Act when the Senate reconvenes on November 29th.
For more on this or other tax matters, please contact Horowitz & Weinstein.